바로가기메뉴

본문 바로가기 주메뉴 바로가기

Etiologic Distribution, Diagnostic Tests and Treatment in Prospectively Registered Patients with DILD fot Two Years in a Tertiary Medical Center

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.58 no.6, pp.570-575











  • Downloaded
  • Viewed

Abstract

Introduction : Diffuse interstitial lung diseases (DILD) comprise of a large group of lung diseases with diverse etiologies. They are classified into four categories based on the etiology and pathological findings. In Korea, epidemiological data on DILD has never been reported in a prospective manner. Method : From May 2002 to April 2004, total 487 patients with DILD were prospectively registered at Samsung Medical Center. The prospective observational analysis of the etiologies, its classification based on 2002 ATS/ERS (American Thoracic Society/European Respiratory Society) guidelines, as well as diagnostic tests and the retrospective analysis of the treatment modalities were carried out. Any infectious and malignant causes were excluded. Results : 1) The patients were classified into idiopathic interstitial pneumonia (IIP) in 269 patients (55.2%), known causes of DILD in 168 patients (34.5%), sarcoidosis in 27 patients (5.5%), other forms of DILD in 14 patients (2.9%), and undetermined DILD in 9 patients (1.9%). 2) The diagnostic test showed that most patients had undergone chest high resolution computed tomography (HRCT) and pulmonary function test (PFT) (97%, 89%). Transbronchial lung biopsy (TBLB) and surgical lung biopsy (SLB) were performed in limited patients (38%, 29%). 3) Among 269 patients with IIP, 220 (82%) had idiopathic pulmonary fibrosis (IPF) while 23 (9%) had nonspecific interstitial pneumonia. SLB was carried out in 36% of patients with IIP. 4) Symptomatic supportive care was given to 67% of IPF, but specific medical treatment including corticosteroids was administered to 89% of non-IPF patients. Conclusion : A nationwide registry of DILD patients is required to determine the annual incidence, etiology, and practice pattern of diagnosis and treatment in Korea. (Tuberc Respir Dis 2005; 58: 570-575)

keywords
Interstitial lung disease, Registry, Etiology, Classification, Interstitial lung disease, Registry, Etiology, Classification

Reference

1.

The diagnosis, (1999) assessment and treatment of diffuse parenchymal lung disease in adults,

2.

Joint Statement of the American Thoracic Society (ATS) the European Respiratory Society (ERS), (1999) Sta tement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS) the European Respiratory Society (ERS) and the World Association of Sarco idosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee,

3.

American Thoracic Society, (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment: international con sensus statement,

4.

Raghu G, (1995) Interstitial lung disease: a diagnostic ap proach: re CT scan and lung biopsy indicated in every patient,

5.

Song JS, (2003) Diagnostic approach in idiopathic interstitial pneumonia,

6.

Thomeer MJ, (2001) Comparison of registries of interstitial lung diseases in three European countries,

7.

Coultas DB, (1994) The epidemiology of interstitial lung diseases,

8.

Coultas DB, (1996) Accuracy of mortality data for interstitial lung diseases in New Mexico,USA,

9.

Kim JH, (1991) The etiology of the diffuse infiltrative dis ease of the lung in Korea,

10.

Lim GI, (1996) Clinical features of interstitial lung diseases,

11.

Liscoet-Loheac N, (2001) Hypersensitivity pneumonitis in a patient taking pravastatin,

12.

Rizzato G, (1999) Inchiesta epidemiologica sulle interstiziopatic polmonari in Italia:dati e risultati a macchia di leopardo,

13.

Padley SP, (1993) High-resolution com puted tomography of the chest:current indications,

14.

Padley SP, (1991) Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease,

15.

du Bois RM, (2001) Cryptogenic fibrosing alveolitis/ idiopathic pulmonary fibrosis.,

16.

American Thoracic Society/European Respiratory So ciety, (2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumo nias: this joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors,

Tuberculosis & Respiratory Diseases